Translation, Cultural Adaptation, and Validation into Romanian of the Myeloproliferative Neoplasm Symptom Assessment Form—Total Symptom Score (MPN-SAF TSS or MPN-10) Questionnaire
Authors:
- Mihnea-Alexandru GămanMihnea-Alexandru Găman
- Robyn Marie ScherberRSRobyn Marie Scherber
- Iulia UrsuleacIUIulia Ursuleac
- Ana Manuela CrişanACAna Manuela Crişan
- Sorina Nicoleta BădeliţăSBSorina Nicoleta Bădeliţă
- Bogdan Octavian IonescuBIBogdan Octavian Ionescu
- Alexandra Elena GhiaurAGAlexandra Elena Ghiaur
- Melen BrînzăMBMelen Brînză
- Nicoleta PîrciulescuNPNicoleta Pîrciulescu
- Toma Octavian LascărTLToma Octavian Lascăr
- Camelia Cristina DiaconuCamelia Cristina Diaconu
- Amelia Maria GămanAGAmelia Maria Găman
Open Access
- 2 June 2024
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (11) , 3284
Abstract
Background: Patients with myeloproliferative neoplasms (MPNs) experience a high disease-related symptom burden. A specific instrument to evaluate quality of life (QoL), i.e., the MPN Symptom Assessment Form Total Symptom Score (MPN-SAF TSS; MPN-10), was developed. We conducted the translation, cultural adaptation, and validation into Romanian of the MPN-10. Methods: We translated the MPN-10 and tested its psychometric properties. Results: We recruited 180 MPN patients: 66 polycythemia vera (36.67%), 61 essential thrombocythemia (33.89%), 51 primary and secondary myelofibrosis (SMF) (28.33%), and 2 MPN-unclassifiable (1.11%). The mean TSS was 19.51 ± 16.51 points. Fatigue, inactivity, and concentration problems were the most cumbersome symptoms. We detected scoring differences between MPN subtypes regarding weight loss (p < 0.001), fatigue (p = 0.006), early satiety (p = 0.007), night sweats (p = 0.047), pruritus (p = 0.05), and TSS (p = 0.021). There were strong positive associations between TSS and inactivity, fatigue, and concentration problems, and moderate negative correlations between QoL scores and all MPN-10 items. Cronbach’s α internal consistency coefficient was 0.855. The Kaiser–Meyer–Olkin construct validity test result was 0.870 and the Bartlett Sphericity Test was significant (p < 0.001). Symptom scores were loaded into one single factor according to the exploratory factor analysis. Conclusions: The Romanian MPN-10 version displayed excellent psychometric properties and is a reliable instrument for assessing symptom burden and QoL in Romanian MPN patients.Keywords
Funding Information
- Competitiveness Operational Programme A1.1.4. ID: P_37_798 MYELOALEDIAPROT (149/26.10.2016 (MySMIS2014+: 106774))
This publication has 15 references indexed in Scilit:
- Meaningful Symptomatic Change in Patients With Myelofibrosis From the SIMPLIFY StudiesValue in Health, 2024
- Patient-reported Outcomes and Quality of Life in Anemic and Symptomatic Patients With Myelofibrosis: Results From the MOMENTUM StudyHemaSphere, 2023
- The international consensus classification of myeloid neoplasms and acute Leukemias: myeloproliferative neoplasmsAmerican Journal of Hematology, 2022
- Improving symptom burden and quality of life in patients with myelofibrosis: current strategies and future directionsExpert Review of Hematology, 2021
- Functional Consequences of Mutations in Myeloproliferative NeoplasmsHemaSphere, 2021
- Quality of Life in Myeloproliferative NeoplasmsHematology/Oncology Clinics of North America, 2021
- Myeloproliferative Neoplasm Symptom Assessment Form - Total Symptom Score (MPN-SAF TSS) questionnaire: translation, cultural adaptation and validation to Brazilian PortugueseHematology, Transfusion and Cell Therapy, 2021
- Classical Philadelphia-negative myeloproliferative neoplasms (MPNs): A continuum of different disease entities2021
- International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL ConsortiumThe Lancet Oncology, 2020
- The rapid assessment of fatigue severity in cancer patientsCancer, 1999